KOPIN CORP

Listed Company

KOPNCIK 0000771266NasdaqNon-AcceleratedSmaller ReportingSemiconductors & Related DevicesDelawareFY ends Dec 27

Period

FY 2025

Revenue

$39.32M

Net Income

$2.61M

Total Assets

$108.39M

Equity

$64.12M

Shares Out

183.36M

Op. Cash Flow

$-15.50M

Business

KOPIN CORP designs and manufactures high-performance microdisplay technologies and integrated optical systems for critical applications. It offers AMLCD, LCOS, OLED and developing MicroLED microdisplays, display drivers, ASICs, optical lenses, backlights, and Application Specific Optical Solutions (ASOS) including subassemblies and headsets. The company operates through market and technology groups organized by segments such as defense, industrial, medical, consumer and AR/VR, leveraging proprietary patents and NeuralDisplay™ architecture. Kopin distributes products globally across the Americas, Asia‑Pacific and Europe through direct programs, prime contractors and government contracts.

Summary from filing dated 2025-04-17

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Total revenues	39	50	40	47	46
Cost of product revenues	28	36	25	33	25
Research and development-Funded	3	4	—	—	—
Research and development Internal	7	6	4	8	6
Selling, general and administrative	16	23	22	18	18
Litigation damages	−5	25	—	—	—
Total operating expenses	49	93	58	69	59
Loss from operations	−10	−43	−17	−22	−14
Interest income	1	817,180	829,602	76,877	31,142
Other income, net	154,194	19,989	245,234	154,357	265,509
Foreign currency transaction gains	286,268	175,909	−162,204	−323,286	139,014
Gain on deconsolidation of subsidiary	11	—	—	—	—
Gain (loss) on investments	1,396	−2	−3	3	—
Total non-operating income (expense)	13	−599,070	−2	3	435,665
Income (loss) before provision for income taxes	3	−44	−20	−19	−13
Provision for income taxes	−208,000	−170,000	−156,000	−144,000	−129,000
Net income (loss)	3	−44	−20	−19	−13
Dividends and deemed dividends on Series A convertible preferred stock	−57,167	—	—	—	—
Net income (loss) attributable to common stockholders	3	−44	—	—	—
Basic (per share)	0.01	−0.33	−0.18	−0.21	−0.15
Diluted (per share)	0.01	−0.33	−0.18	−0.21	−0.15
Basic (shares)	171	133	109	91	89
Diluted (shares)	175	133	109	91	89

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	36	14	—	—	—
Restricted cash and cash equivalents	25	1	500,000	—	—
Marketable securities, at fair value	—	21	12	4	3
Accounts receivable, net of allowance of $19,000 and $1,075,000 in 2025 and 2024, respectively	11	12	10	7	12
Contract assets	6	7	3	4	2
Inventory	6	6	8	6	7
Other receivable, at fair value	5	—	—	—	—
Prepaid expenses and other current assets	3	1	1	1	2
Total current assets	92	63	40	31	52
Property, plant and equipment, net	3	2	2	2	2
Operating lease right-of-use assets	1	2	3	3	4
Other assets	123,822	123,822	124,925	170,132	170,932
Equity method investment, at fair value	9	—	—	—	—
Equity investments	3	4	—	—	—
Total assets	108	71	49	44	63
Accounts payable	5	6	5	5	5
Accrued payroll and expenses	2	2	2	3	2
Accrued warranty	1	3	2	2	517,000
Contract liabilities	1	87,752	900,000	930,500	4
Deferred grant income	3	—	—	—	—
Operating lease liabilities	648,469	639,642	651,503	786,928	701,204
Accrued post-retirement benefits	40,000	40,000	—	—	—
Other accrued liabilities	422,440	685,946	2	1	1
Accrued legal expenses	185,475	6	2	—	—
Deferred tax liabilities	422,458	414,118	470,884	482,739	—
Accrued litigation damages	20	25	—	—	—
Total current liabilities	34	44	16	14	18
Noncurrent contract liabilities and asset retirement obligations	3,675	358,292	278,112	248,284	288,634
Operating lease liabilities, net of current portion	831,507	1	2	3	3
Accrued post-retirement benefits, net of current portion	190,696	230,646	—	—	—
Other long-term liabilities, net of current portion	2	1	1	1	1
Total liabilities	37	47	20	20	23
Commitments and contingencies (Note 13) and Litigation (Note 14)	—	—	—	—	—
Preferred stock, par value $.01 per share: authorized, 3,000 shares; no shares issued and outstanding as of 2025 and 2024	—	—	—	—	—
Common stock, par value $0.01; 275,000,000 shares authorized, 183,015,207 issued, and 176,903,857 outstanding at December 27, 2025; 200,000,000 shares authorized, 161,264,507 issued, and 156,118,014 outstanding at December 28, 2024	2	2	1	929,540	900,691
Additional paid-in capital	463	422	385	361	357
Treasury stock 771,500 shares in 2025 and 312,882 shares in 2024, at cost)	−1	−370,012	−103,127	−103,127	−366,110
Accumulated other comprehensive income	—	2	1	1	1
Accumulated deficit	−399	−402	−358	−338	−319
Total stockholders equity	64	23	30	24	40
Total liabilities, redeemable convertible preferred stock, and stockholders equity	108	71	49	44	63

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net income (loss)	3	−44	—	—	—
Depreciation and amortization	829,554	636,580	608,222	722,024	668,691
Stock-based compensation	3	3	4	1	4
Non-cash (gain) loss on equity investments	−161,406	2	—	—	—
Gain on sale of equity investment	−300,000	—	3	−3	−300,000
Gain on deconsolidation of subsidiary	−11	—	—	—	—
Income taxes	208,912	170,642	—	143,345	128,279
Foreign currency gains	−326,085	−207,926	91,791	449,443	−186,942
Loss on disposal of property and equipment	88,236	59,151	46,231	317,032	99,228
Provision for credit losses	10,000	105,842	709,721	162,638	—
Noncash provision for excess inventory	968,116	2	1	2	—
Accrued litigation damages	−5	25	—	—	—
Accounts receivable	896,158	−2	−5	7	−3
Contract assets	942,197	−4	821,094	−2	1
Inventory	−1	−922,589	−2	−2	−3
Prepaid expenses and other current assets	−2	53,610	−202,504	908,156	−691,573
Other assets	−240,646	—	—	—	—
Accounts payable and accrued expenses	−7	4	2	−4	143,379
Accrued warranty	−1	396,451	—	—	—
Contract liabilities	4	−845,041	3,568	−3	3
Net cash used in operating activities	−16	−14	−15	−18	−11
Proceeds from sale of marketable securities	36	10	10	2	1
Proceeds from sale of equity investment	300,000	—	—	—	—
Other assets	—	−45	62,694	20,909	−12,822
Capital expenditures	−1	−815,299	−949,487	−832,712	−1
Deconsolidation of subsidiary cash	−419,383	—	—	—	—
Payments to equity method investee	−2	—	—	—	—
Purchases of marketable securities	−15	−19	−18	−4	—
Net cash used in investing activities	18	−10	−8	−3	53,675
Issuance of common stock and pre-funded warrants, net of costs	38	34	21	2	—
Issuance of preferred stock, net of costs	7	—	—	—	—
Settlements of restricted stock for tax withholding obligations	−1	−266,885	—	−198,740	−602,080
Net cash provided by financing activities	44	34	21	3	20
Effect of exchange rate changes on cash	3,993	−952	14,463	−190,585	−80,124
Net change in cash, cash equivalents and restricted cash	46	9	−2	−19	10
Construction in progress included in accrued expenses	3,600	17,000	—	—	—
Right-of-use asset obtained in exchange for lease liability	—	217,046	—	—	—
Interest paid, net of amounts capitalized	—	—	—	—	—
Cash paid for income taxes	—	—	—	—	—
Accrued dividends	28,000	—	—	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro